Q&A with hVIVO’s Mo Khan: “£80 million is the highest starting order book in the history of the company

Episode 1793,   Jan 30, 08:07 AM

Vox Markets talks to hVIVO chief executive Mo Khan on a year that saw the human challenge trial specialist beat previously upgraded Ebitda guidance and start 2024 with the company’s highest ever starting order book, laying a solid foundation for its next phase of growth.

0:29 Mo Khan talks through the highlights of hVIVO’s expectation-beating FY23 trading update.
1:28 How operational gearing is flowing through into a rapidly increasing Ebitda margin.
2:22 What’s behind the increase in the order book to a record £80m, including an expanded range of human challenge models and increasing contract sizes.
4:07 The outlook for 2024, including 90% of revenue already contracted and the opening of the Canary Wharf facility that expands the group’s revenue capacity to over £90m of annual revenue.
5:31 How the new facility will further support margin expansion.
6:03 Other ambitions in the short to medium term, including £100m revenue by 2028, driven both organically and through bolt-on acquisitions.
7:26 The introduction of a dividend policy and the cash generative qualities of the group that underpins it.